Cancer Genetics CEO Moderates Panel Discussion With Thought Leaders in Biopharma at the BioNJ 2014 International BioPartnering Conference
By Jamie on April 10 2014
Panna Sharma, CEO of Cancer Genetics, Is Moderating a Panel Entitled Partnering for a Balanced Portfolio: Perspectives from Innovators, Partners, & Payers RUTHERFORD, N.J., April 10, 2014 Cancer Genetics, Inc. (Nasdaq: CGIX) (“CGI” or the “Company”), an emerging leader in DNA-based cancer diagnostics, announced that the Company is a sponsor of the BioNJ International […]
Continue ReadingCancer Genetics Announces Launch of CALR Mutation Analysis Test to Assist in Diagnosis of Acute Leukemias & Myeloproliferative Neoplasms
By Jamie on April 4 2014
New Test Launch Extends CGI’s Leadership in Genomic Testing for Blood Cancers CALR Genetic Mutation Test Will Be A Part of CGI’s Comprehensive Focus on Leukemia RUTHERFORD, N.J., April 4, 2014 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or the “Company”), an emerging leader in DNA-based cancer diagnostics, has launched a genetic diagnostic test for […]
Continue ReadingCancer Genetics to Present New Data from Renal Cell Carcinoma Study at AACR
By Jamie on April 3 2014
Genomic Alterations Identified in Study Could Potentially Serve as Biomarkers for Metastasis in RCC RUTHERFORD, NJ April 3, 2014 Cancer Genetics, Inc. (NASDAQ: CGIX), an emerging leader in DNA-based diagnostics, announced today that a poster highlighting preliminary results of a study in clear cell Renal Cell Carcinoma (ccRCC) will be presented at the 105th Annual […]
Continue Reading